Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

Novartis building

Novartis files COPD combo in US

QVA149 combines long-acting beta agonist with long-acting muscarinic antagonist

Bristol-Myers Squibb (BMS) building

BMS’ Opdivo set for early access in UK

First anti-PD1 to be given fast-track status in the country

Pharma deals during December 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for December 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Novartis completes sale of animal health unit to Lilly

$5.4bn deal is finalised

- PMLiVE

Bayer names head of pharma comms in US

Steven Immergut joins from the US FDA

- PMLiVE

Pfizer buys majority stake in Redvax

Will see the US pharma company gain access to early stage vaccine projects

- PMLiVE

Novartis signs stem cell research pact with Intellia

Will work with the biotech start-up on creating new treatments

- PMLiVE

Liberation names account manager

Promotion for Danielle Guildford-Sharp

- PMLiVE

NICE set to dismiss Millennium’s Crohn’s drug Entyvio

Body cites uncertain evidence and unlikely value for the NHS

- PMLiVE

Type 2 diabetes market in Asia-Pacific to hit $10.5bn by 2020

Analysts predict increase of $4bn from 2013 figure

- PMLiVE

Amgen and Kite in $1bn cancer immunotherapy tie up

Latest major research deal in growing area of oncology

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links